Dey Curasurf
Executive Summary
Porcine-derived lung surfactant Curasurf (poractant) is designated as "approvable" by FDA for respiratory distress syndrome in premature infants Sept. 4. The company's first NDA submission, Dey filed the Curasurf NDA July 3, 1996. Curasurf is licensed from the Italian firm Chiesi and is marketed in Europe by Serono